diaziquone has been researched along with aclarubicin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abeloff, MD; Camacho, FJ; Chang, AY; Creech, RH; Ettinger, DS; Finkelstein, DM | 1 |
| Camacho, FJ; Chang, AY; Ettinger, DS; Finkelstein, DM; Harper, GR; Marsh, JC; Ruckdeschel, JC; Silber, R; Wolter, JM | 1 |
2 trial(s) available for diaziquone and aclarubicin
| Article | Year |
|---|---|
Phase II study of aclarubicin and diaziquone in the treatment of advanced small cell bronchogenic carcinoma (EST 4581): an Eastern Cooperative Oncology Group Study.
Topics: Aclarubicin; Adult; Aged; Aziridines; Azirines; Benzoquinones; Brain Neoplasms; Carcinoma, Bronchogenic; Drug Evaluation; Female; Humans; Infusions, Parenteral; Lung Neoplasms; Male; Middle Aged; Naphthacenes; Random Allocation | 1985 |
Phase II study of mitoxantrone, aclarubicin, and diaziquone in the treatment of non-small cell lung carcinoma: an Eastern Cooperative Oncology Group study.
Topics: Aclarubicin; Aged; Anaphylaxis; Anthraquinones; Antineoplastic Combined Chemotherapy Protocols; Aziridines; Benzoquinones; Drug Evaluation; Female; Hematologic Diseases; Humans; Infusions, Parenteral; Lung Neoplasms; Male; Middle Aged; Mitoxantrone; Naphthacenes | 1985 |